Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Artificial Intelligence (AI) In Respiratory Diseases Global Market Report 2025
Request Sample Buy Now
Global Artificial Intelligence (AI) In Respiratory Diseases Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Artificial Intelligence (AI) In Respiratory Diseases Global Market Report 2025

By Imaging Type (Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)), By Indication (Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection), By End Use (Hospital, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Artificial Intelligence (AI) In Respiratory Diseases Market Overview

• Artificial Intelligence (AI) In Respiratory Diseases market size has reached to $7.66 billion in 2024

• Expected to grow to $9.7 billion in 2029 at a compound annual growth rate (CAGR) of 5%

• Growth Driver: AI Revolutionizing Respiratory Health Addressing The Impact Of Growing Environmental Pollution

• Market Trend: TidalSense Launches N-Tidal Device For AI-Driven Respiratory Disease Management

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Artificial Intelligence (AI) In Respiratory Diseases Market?

Artificial intelligence (AI) in respiratory diseases refers to the use of AI and machine learning techniques to aid clinicians in the diagnosis, management, and treatment of various respiratory conditions. It has numerous potential applications in pulmonary medicine, including image analysis, predictive modeling, and disease management.

The main imaging types of artificial intelligence (AI) in respiratory diseases are Magnetic Resonance Imaging (MRI), computed tomography (CT) scan, and electronic patient-reported outcomes (ePRO). AI in chronic obstructive pulmonary disease refers to the application of artificial intelligence (AI) technologies in the diagnosis, management, and treatment of COPD. It is used for the treatment of various indications such as chronic obstructive pulmonary disease, interstitial lung disease, and pulmonary infection, by several end-users, including hospital, diagnostic centers, ambulatory surgical centers, and others.

Artificial Intelligence (AI) In Respiratory Diseases Market Size and growth rate 2025 to 2029: Graph

What Is The Artificial Intelligence (AI) In Respiratory Diseases Market Size 2025 And Growth Rate?

The artificial intelligence (AI) in respiratory diseases market size has grown strongly in recent years. It will grow from $7.66 billion in 2024 to $7.98 billion in 2025 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to increasing government regulations, growing environmental concerns, increasing aging population, growing patient-centric healthcare approaches, rise in healthcare infrastructure development.

What Is The Artificial Intelligence (AI) In Respiratory Diseases Market Growth Forecast?

The artificial intelligence (AI) in respiratory diseases market size is expected to see strong growth in the next few years. It will grow to $9.7 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to increasing prevalence of respiratory diseases, rising need for early detection and diagnosis, growing environmental pollution, rising healthcare expenditure, research and development initiatives. Major trends in the forecast period include technological advancements, drug discovery and development, personalized treatment plans, telemedicine and remote patient monitoring, remote patient monitoring.

The forecast of 5.0% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. pulmonary care by inflating prices of Artificial intelligence(AI)-enabled spirometry devices and cough pattern recognition software developed in Israel and Germany, resulting in delayed COPD/asthma interventions and higher respiratory clinic costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Artificial Intelligence (AI) In Respiratory Diseases Market Segmented?

1) By Imaging Type: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)

2) By Indication: Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection

3) By End Use: Hospital, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Magnetic Resonance Imaging (MRI): Lung Imaging, Thoracic Imaging, Cardiopulmonary Imaging

2) By Computed Tomography (CT) Scan: High-Resolution CT (HRCT), Low-Dose CT, Thoracic CT

3) By Electronic Patient-Reported Outcomes (ePRO): Symptom Tracking, Medication Adherence Monitoring, Quality Of Life Assessments

What Is Driving The Artificial Intelligence (AI) In Respiratory Diseases Market? AI Revolutionizing Respiratory Health Addressing The Impact Of Growing Environmental Pollution

Growing environmental pollution is expected to propel the growth of artificial intelligence (AI) in the respiratory disease market going forward. Environmental pollution refers to the addition of any substance or form of energy to the environment at a rate faster than IT can be dispersed or stored in a harmless form. AI in respiratory diseases has the potential to significantly reduce the impact of environmental pollution on respiratory health by offering real-time monitoring, personalized risk assessments, informed decision-making, and innovative solutions for both individuals and communities. For instance, in June 2024, according to the US Energy Information Administration, a US-based government agency, the CO2 emission in 2021 accounted for 35.72 billion metric tons which increased to 38.50 billion metric tons in 2022. Therefore, growing environmental pollution is driving the growth of artificial intelligence (AI) in the respiratory disease market.

Who Are The Major Players In The Global Artificial Intelligence (AI) In Respiratory Diseases Market?

Major companies operating in the artificial intelligence (AI) in respiratory diseases market report are Siemens Healthineers, Philips Healthcare, General Electric (GE) Healthcare, Verily Life Sciences LLC, DeepMind Health, Merative L.P., Innovaccer, Freenome, Aidoc Medical, Butterfly Network, Infervision, Imagen Technologies, Caption Health, Gauss Surgical Inc., Swaasa AI, Inspirata Inc., VIDA Diagnostics Inc., Enlitic, Thirona B.v., ArtiQ, Icometrix, Zynnon AG, Aidence, Arterys, Dectrocel Healthcare, PneumoWave Ltd.

What Are The Key Trends Of The Global Artificial Intelligence (AI) In Respiratory Diseases Market? TidalSense Launches N-Tidal Device For AI-Driven Respiratory Disease Management

Major companies operating in artificial intelligence (AI) in the respiratory diseases market are developing innovative products such as N-Tidal devices to monitor patients' tidal breathing. The n-Tidal device measures the volume of air exchanged during normal breathing and provides valuable information about lung function. For instance, in August 2023, TidalSense, a UK-based respiratory technology company, launched N-Tidal, a regulated AI technology for chronic obstructive pulmonary disease (COPD) diagnosis and management. The technology combines N-Tidal's CO2 sensor data with an artificial intelligence platform to measure changes in lung function, aiming to improve the diagnosis and management of this respiratory condition. Clinical studies have demonstrated the technology's high accuracy, and IT is expected to reform the diagnostic process for respiratory diseases. The launch is a significant development in the use of AI for respiratory disease assessment, offering a more comfortable and efficient alternative to existing diagnostic tests.

Need data on a specific region in this market?
Request Customisation

What Are Latest Mergers And Acquisitions In The Artificial Intelligence (AI) In Respiratory Diseases Market? Resmed Inc. Expands Sleep And Respiratory Care Portfolio With Acquisition Of Somnoware

In July 2023, ResMed Inc., a US-based medical equipment company that provides cloud-connectable medical devices, acquired Somnoware for an undisclosed amount. This acquisition strengthens ResMed's sleep and respiratory care portfolio and complements its existing digital respiratory healthcare tools. The acquisition is expected to enhance the management of patient data, ordering of treatment equipment, scheduling appointments, and tracking compliance, ultimately improving patient experience and health outcomes. Somnoware is a US-based cloud-based platform for enhanced respiratory care management and hospital-at-home care.

What Is The Regional Outlook For The Global Artificial Intelligence (AI) In Respiratory Diseases Market?

North America was the largest region in the artificial Intelligence (AI) in respiratory diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Artificial Intelligence (AI) In Respiratory Diseases Market?

The artificial Intelligence (AI) in respiratory diseases market includes revenues earned by entities by providing services such as AI-assisted imaging analysis, digital pathology platforms, and AI-powered rehabilitation programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in respiratory diseases market also includes sales IoT devices, wearables, and smart inhalers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Artificial Intelligence (AI) In Respiratory Diseases Industry?

The artificial intelligence (ai) in respiratory diseases market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (ai) in respiratory diseases industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Artificial Intelligence (AI) In Respiratory Diseases Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $7.98 billion
Revenue Forecast In 2034 $9.7 billion
Growth Rate CAGR of 5% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Imaging Type: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)
2) By Indication: Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection
3) By End Use: Hospital, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users Subsegments: 1) By Magnetic Resonance Imaging (MRI): Lung Imaging, Thoracic Imaging, Cardiopulmonary Imaging
2) By Computed Tomography (CT) Scan: High-Resolution CT (HRCT), Low-Dose CT, Thoracic CT
3) By Electronic Patient-Reported Outcomes (ePRO): Symptom Tracking, Medication Adherence Monitoring, Quality Of Life Assessments
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Siemens Healthineers, Philips Healthcare, General Electric (GE) Healthcare, Verily Life Sciences LLC, DeepMind Health, Merative L.P., Innovaccer, Freenome, Aidoc Medical, Butterfly Network, Infervision, Imagen Technologies, Caption Health, Gauss Surgical Inc., Swaasa AI, Inspirata Inc., VIDA Diagnostics Inc., Enlitic, Thirona B.v., ArtiQ, Icometrix, Zynnon AG, Aidence, Arterys, Dectrocel Healthcare, PneumoWave Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Artificial Intelligence (AI) In Respiratory Diseases Market Characteristics

3. Artificial Intelligence (AI) In Respiratory Diseases Market Trends And Strategies

4. Artificial Intelligence (AI) In Respiratory Diseases Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Intelligence (AI) In Respiratory Diseases Growth Analysis And Strategic Analysis Framework

5.1. Global Artificial Intelligence (AI) In Respiratory Diseases PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Artificial Intelligence (AI) In Respiratory Diseases Market Growth Rate Analysis

5.4. Global Artificial Intelligence (AI) In Respiratory Diseases Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Artificial Intelligence (AI) In Respiratory Diseases Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Artificial Intelligence (AI) In Respiratory Diseases Total Addressable Market (TAM)

6. Artificial Intelligence (AI) In Respiratory Diseases Market Segmentation

6.1. Global Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Magnetic Resonance Imaging (MRI)

Computed Tomography (CT) Scan

Electronic Patient-Reported Outcomes (ePRO)

6.2. Global Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Chronic Obstructive Pulmonary Disease

Interstitial Lung Disease

Pulmonary Infection

6.3. Global Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital

Diagnostic Centers

Ambulatory Surgical Centers

Other End-Users

6.4. Global Artificial Intelligence (AI) In Respiratory Diseases Market, Sub-Segmentation Of Magnetic Resonance Imaging (MRI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Lung Imaging

Thoracic Imaging

Cardiopulmonary Imaging

6.5. Global Artificial Intelligence (AI) In Respiratory Diseases Market, Sub-Segmentation Of Computed Tomography (CT) Scan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

High-Resolution CT (HRCT)

Low-Dose CT

Thoracic CT

6.6. Global Artificial Intelligence (AI) In Respiratory Diseases Market, Sub-Segmentation Of Electronic Patient-Reported Outcomes (ePRO), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Symptom Tracking

Medication Adherence Monitoring

Quality Of Life Assessments

7. Artificial Intelligence (AI) In Respiratory Diseases Market Regional And Country Analysis

7.1. Global Artificial Intelligence (AI) In Respiratory Diseases Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Artificial Intelligence (AI) In Respiratory Diseases Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence (AI) In Respiratory Diseases Market

8.1. Asia-Pacific Artificial Intelligence (AI) In Respiratory Diseases Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence (AI) In Respiratory Diseases Market

9.1. China Artificial Intelligence (AI) In Respiratory Diseases Market Overview

9.2. China Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence (AI) In Respiratory Diseases Market

10.1. India Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence (AI) In Respiratory Diseases Market

11.1. Japan Artificial Intelligence (AI) In Respiratory Diseases Market Overview

11.2. Japan Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence (AI) In Respiratory Diseases Market

12.1. Australia Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence (AI) In Respiratory Diseases Market

13.1. Indonesia Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence (AI) In Respiratory Diseases Market

14.1. South Korea Artificial Intelligence (AI) In Respiratory Diseases Market Overview

14.2. South Korea Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence (AI) In Respiratory Diseases Market

15.1. Western Europe Artificial Intelligence (AI) In Respiratory Diseases Market Overview

15.2. Western Europe Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence (AI) In Respiratory Diseases Market

16.1. UK Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence (AI) In Respiratory Diseases Market

17.1. Germany Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence (AI) In Respiratory Diseases Market

18.1. France Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence (AI) In Respiratory Diseases Market

19.1. Italy Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence (AI) In Respiratory Diseases Market

20.1. Spain Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence (AI) In Respiratory Diseases Market

21.1. Eastern Europe Artificial Intelligence (AI) In Respiratory Diseases Market Overview

21.2. Eastern Europe Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence (AI) In Respiratory Diseases Market

22.1. Russia Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence (AI) In Respiratory Diseases Market

23.1. North America Artificial Intelligence (AI) In Respiratory Diseases Market Overview

23.2. North America Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence (AI) In Respiratory Diseases Market

24.1. USA Artificial Intelligence (AI) In Respiratory Diseases Market Overview

24.2. USA Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence (AI) In Respiratory Diseases Market

25.1. Canada Artificial Intelligence (AI) In Respiratory Diseases Market Overview

25.2. Canada Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence (AI) In Respiratory Diseases Market

26.1. South America Artificial Intelligence (AI) In Respiratory Diseases Market Overview

26.2. South America Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence (AI) In Respiratory Diseases Market

27.1. Brazil Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence (AI) In Respiratory Diseases Market

28.1. Middle East Artificial Intelligence (AI) In Respiratory Diseases Market Overview

28.2. Middle East Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence (AI) In Respiratory Diseases Market

29.1. Africa Artificial Intelligence (AI) In Respiratory Diseases Market Overview

29.2. Africa Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence (AI) In Respiratory Diseases Market Competitive Landscape And Company Profiles

30.1. Artificial Intelligence (AI) In Respiratory Diseases Market Competitive Landscape

30.2. Artificial Intelligence (AI) In Respiratory Diseases Market Company Profiles

30.2.1. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Philips Healthcare Overview, Products and Services, Strategy and Financial Analysis

30.2.3. General Electric (GE) Healthcare Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Verily Life Sciences LLC Overview, Products and Services, Strategy and Financial Analysis

30.2.5. DeepMind Health Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence (AI) In Respiratory Diseases Market Other Major And Innovative Companies

31.1. Merative L.P.

31.2. Innovaccer

31.3. Freenome

31.4. Aidoc Medical

31.5. Butterfly Network

31.6. Infervision

31.7. Imagen Technologies

31.8. Caption Health

31.9. Gauss Surgical Inc.

31.10. Swaasa AI

31.11. Inspirata Inc.

31.12. VIDA Diagnostics Inc.

31.13. Enlitic

31.14. Thirona B.v.

31.15. ArtiQ

32. Global Artificial Intelligence (AI) In Respiratory Diseases Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence (AI) In Respiratory Diseases Market

34. Recent Developments In The Artificial Intelligence (AI) In Respiratory Diseases Market

35. Artificial Intelligence (AI) In Respiratory Diseases Market High Potential Countries, Segments and Strategies

35.1 Artificial Intelligence (AI) In Respiratory Diseases Market In 2029 - Countries Offering Most New Opportunities

35.2 Artificial Intelligence (AI) In Respiratory Diseases Market In 2029 - Segments Offering Most New Opportunities

35.3 Artificial Intelligence (AI) In Respiratory Diseases Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Sub-Segmentation Of Magnetic Resonance Imaging (MRI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Sub-Segmentation Of Computed Tomography (CT) Scan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Sub-Segmentation Of Electronic Patient-Reported Outcomes (ePRO), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Siemens Healthineers Financial Performance
  • Table 78: Philips Healthcare Financial Performance
  • Table 79: General Electric (GE) Healthcare Financial Performance
  • Table 80: Verily Life Sciences LLC Financial Performance
  • Table 81: DeepMind Health Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Sub-Segmentation Of Magnetic Resonance Imaging (MRI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Sub-Segmentation Of Computed Tomography (CT) Scan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Sub-Segmentation Of Electronic Patient-Reported Outcomes (ePRO), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Siemens Healthineers Financial Performance
  • Figure 78: Philips Healthcare Financial Performance
  • Figure 79: General Electric (GE) Healthcare Financial Performance
  • Figure 80: Verily Life Sciences LLC Financial Performance
  • Figure 81: DeepMind Health Financial Performance

Next-Gen Primary Health Care Service : Market Forecast, Transformation, and Long-Term Trajectories

Read More About Next-Gen Primary Health Care Service : Market Forecast, Transformation, and Long-Term Trajectories

Progressive Ataxia And Weakness Disorders Growth Trajectory: Key Forecasts and Strategic Insights

Read More About Progressive Ataxia And Weakness Disorders Growth Trajectory: Key Forecasts and Strategic Insights

Prostate Cancer Nuclear Medicine Diagnostics Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Read More About Prostate Cancer Nuclear Medicine Diagnostics Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the Prostate Cancer Nuclear Medicine Diagnostics Market Landscape: Automated Parallel Capillary Electrophoresis Systems Transforming Protein Analysis In The Protein Chip Market

Read More About Emerging Trends Redefining the Prostate Cancer Nuclear Medicine Diagnostics Market Landscape: Automated Parallel Capillary Electrophoresis Systems Transforming Protein Analysis In The Protein Chip Market

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Automotive Films Market 2023 – By Film Type (Automotive Films Window Film, Paint Protection Films (PPF), Wrap Film), By Vehicle Type (Passenger, Commercial), By Application (Interior, Exterior ), By Material Type (Dyed, ...

View Report

Tax Management Market 2023 – By Component (Software, Services), By Deployment Mode (Cloud, On-Premises), By Vertical (Corporate Banking Financial Services And Insurance (BFSI), Information Technology (IT) And Telecom, Ma...

View Report

Packaging Adhesives Global Market Report 2025 – By Technology (Water-Based, Solvent-Based, Hot Melt), By Resins (Poly Vinyl Acetate (PVA), Acrylics, Polyurethane, Other Resins), By Application (Flexible Packaging, Foldin...

View Report

Pulse Oximeter Global Market Report 2025 – By Product Type (Fingertip, Handheld, Wrist-worn, Table-Top And Bedside), By Technology (Conventional, Connected), By Age Group (Adult, Pediatric), By End-User (Hospitals And Cl...

View Report

Embedded Automation Computers Global Market Report 2025 – By Type (Single Board Computers (SBC), Rugged Industrial Box PC, Vehicle Computer, Internet of Things (IoT) Gateways), By Application (Industrial Automation, Tran...

View Report

Military Displays Global Market Report 2025 – By Type( Smart Displays, Conventional Displays), By Technology( LED, LCD, AMOLED, OLED), By Computer Display( Microdisplays, Small and Medium-Sized Panels, Large Panels), By ...

View Report

Frequently Asked Questions

Artificial intelligence (AI) in respiratory diseases refers to the use of AI and machine learning techniques to aid clinicians in the diagnosis, management, and treatment of various respiratory conditions. It has numerous potential applications in pulmonary medicine, including image analysis, predictive modeling, and disease management. For further insights on this market, request a sample here

The market major growth driver - AI Revolutionizing Respiratory Health Addressing The Impact Of Growing Environmental Pollution. For further insights on this market, request a sample here

The artificial intelligence (AI) in respiratory diseases market size has grown steadily in recent years. It will grow from $7.66 billion in 2024 to $7.98 billion in 2025 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to increasing government regulations, growing environmental concerns, increasing aging population, growing patient-centric healthcare approaches, rise in healthcare infrastructure development. The artificial intelligence (AI) in respiratory diseases market size is expected to see steady growth in the next few years. It will grow to " $9.7 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to increasing prevalence of respiratory diseases, rising need for early detection and diagnosis, growing environmental pollution, rising healthcare expenditure, research and development initiatives. Major trends in the forecast period include technological advancements, drug discovery and development, personalized treatment plans, telemedicine and remote patient monitoring, remote patient monitoring. For further insights on this market, request a sample here

The artificial intelligence (AI) in respiratory diseasesmarket covered in this report is segmented –
1) By Imaging Type: Magnetic Resonance Imaging (MRI); Computed Tomography (CT) Scan; Electronic Patient-Reported Outcomes (ePRO)
2) By Indication: Chronic Obstructive Pulmonary Disease; Interstitial Lung Disease; Pulmonary Infection
3) By End Use: Hospital; Diagnostic Centers; Ambulatory Surgical Centers; Other End-Users Subsegments:
1) By Magnetic Resonance Imaging (MRI): Lung Imaging; Thoracic Imaging; Cardiopulmonary Imaging
2) By Computed Tomography (CT) Scan: High-Resolution CT (HRCT); Low-Dose CT; Thoracic CT
3) By Electronic Patient-Reported Outcomes (ePRO): Symptom Tracking; Medication Adherence Monitoring; Quality Of Life Assessments For further insights on this market, request a sample here

North America was the largest region in the artificial Intelligence (AI) in respiratory diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in respiratory diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the artificial intelligence (AI) in respiratory diseases market report are Siemens Healthineers, Philips Healthcare, General Electric (GE) Healthcare, Verily Life Sciences LLC, DeepMind Health, Merative L.P., Innovaccer, Freenome, Aidoc Medical, Butterfly Network, Infervision, Imagen Technologies, Caption Health, Gauss Surgical Inc., Swaasa AI, Inspirata Inc., VIDA Diagnostics Inc., Enlitic, Thirona B.v., ArtiQ, Icometrix, Zynnon AG, Aidence, Arterys, Dectrocel Healthcare, PneumoWave Ltd.. For further insights on this market, request a sample here.

Major trends in this market include TidalSense Launches N-Tidal Device For AI-Driven Respiratory Disease Management. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Artificial Intelligence (AI) In Respiratory Diseases Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon